| Trial ID: | L0086 |
| Source ID: | NCT03695107
|
| Associated Drug: |
Nifedipine Controlled Released Tablets
|
| Title: |
Clinical Study on the Effect of PTH on CYP3A4 Activity
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases
|
| Interventions: |
DRUG: Nifedipine controlled released tablets
|
| Outcome Measures: |
Primary: the concentration of nifedipine, the concentration of nifedipine, at 5-7days | Secondary: 24-hour ambulatory blood pressure, mean blood pressure, at 1 day and 7day
|
| Sponsor/Collaborators: |
Sponsor: The Third Xiangya Hospital of Central South University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
200
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2019-10-02
|
| Completion Date: |
2020-09-10
|
| Results First Posted: |
|
| Last Update Posted: |
2019-09-19
|
| Locations: |
The Third Xiangya Hospital of Central South University , , China,, Changsha, Hunan, 410013, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03695107
|
